Eton Pharmaceutcials Inc (ETON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 13,132 | 1,554 | -4,601 | -6,084 | -4,157 |
| Depreciation Amortization | 2,795 | 1,249 | 4,740 | 3,548 | 2,360 |
| Accounts receivable | -13,129 | -1,651 | -6,396 | -7,721 | -9,092 |
| Accounts payable and accrued liabilities | 3,429 | 2,508 | 6,808 | 10,092 | 7,970 |
| Other Working Capital | -5,879 | 2,491 | -859 | 16,515 | 6,061 |
| Other Operating Activity | 14,312 | 1,254 | 10,832 | 5,725 | 6,907 |
| Operating Cash Flow | $14,660 | $7,405 | $10,524 | $22,075 | $10,049 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -70 | -75 | -333 | -284 | N/A |
| Purchase Sale Intangibles | -15,000 | -15,000 | N/A | N/A | N/A |
| Other Investing Activity | -15,000 | -15,000 | 0 | 0 | 0 |
| Investing Cash Flow | $-15,070 | $-15,075 | $-333 | $-284 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -3,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 4,313 | 1,389 | 815 | 394 | 394 |
| Financing Cash Flow | $1,313 | $1,389 | $815 | $394 | $394 |
| Beginning Cash Position | 25,942 | 25,942 | 14,936 | 14,936 | 14,936 |
| End Cash Position | 26,845 | 19,661 | 25,942 | 37,121 | 25,379 |
| Net Cash Flow | $903 | $-6,281 | $11,006 | $22,185 | $10,443 |
| Free Cash Flow | |||||
| Operating Cash Flow | 14,660 | 7,405 | 10,524 | 22,075 | 10,049 |
| Capital Expenditure | -70 | -75 | -333 | -284 | N/A |
| Free Cash Flow | 14,590 | 7,330 | 10,191 | 21,791 | 10,049 |